Alfa Cytology announced its pancreatic cancer research services for anticancer therapy in the early preclinical stages. Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer preclinical research services with robust platforms, powerful analytics, and cross-platform collaborations. Pancreatic cancer (PC) is a severe disease that is difficult to diagnose in the early stages due to its complex and hidden nature. Studies found that the incidenc...

  Alfa Cytology has announced its molecular biology services for TME research. Alfa Cytology, a specialized biotechnology company headquartered in the United States, focusing on tumor microenvironment (TME), has announced its molecular biology services for TME research. The launch of the service indicates that the company is developing towards precision and depth in TME research. TME refers to the surrounding environment of tumor cells, which feed the latter as normal cells, molecules, and blood...